{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:02:03Z","timestamp":1789538523984,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-026-01830-2","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:55:58Z","timestamp":1789527358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent Advances in Surveillance Strategies for Nasopharyngeal Carcinoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Rong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caineng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"1830_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, et al. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380.","journal-title":"Lancet"},{"key":"1830_CR2","volume-title":"Global Cancer Observatory: Cancer Today","author":"J Ferlay","year":"2024","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2024."},{"key":"1830_CR3","unstructured":"Ferlay J et al. Data visualization tools for exploring the global cancer burden in 2020."},{"key":"1830_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","volume":"374","author":"LL Tang","year":"2016","unstructured":"Tang LL, Chen WQ, Xue WQ, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016;374:22\u201330.","journal-title":"Cancer Lett"},{"key":"1830_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40880-017-0257-9","volume":"36","author":"KR Wei","year":"2017","unstructured":"Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36:90.","journal-title":"Chin J Cancer"},{"key":"1830_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KCW Wong","year":"2021","unstructured":"Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol. 2021;18:679\u201395.","journal-title":"Nat Rev Clin Oncol"},{"issue":"17","key":"1830_CR7","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.7150\/jca.45767","volume":"11","author":"F Wang","year":"2020","unstructured":"Wang F, Jiang C, Wang L, et al. Different risk target volumes for nasopharyngeal carcinoma treated with simultaneous integrated boost intensitymodulated radiotherapy. J Cancer. 2020;11(17):5210\u201322.","journal-title":"J Cancer"},{"key":"1830_CR8","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/hed.25545","volume":"41","author":"YM Tian","year":"2019","unstructured":"Tian YM, Liu MZ, Zeng L, Bai L, Lin CG, Huang SM, et al. Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Head Neck. 2019;41:1246\u201352.","journal-title":"Head Neck"},{"key":"1830_CR9","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S1470-2045(24)00504-7","volume":"25","author":"SL Liu","year":"2024","unstructured":"Liu SL, Li XY, Yang JH, et al. Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2024;25:1563\u201375.","journal-title":"Lancet Oncol"},{"key":"1830_CR10","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/S0140-6736(24)00594-4","volume":"403","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang Y, Yang KY, et al. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): A multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet. 2024;403:2720\u201331.","journal-title":"Lancet"},{"issue":"suppl 16","key":"1830_CR11","doi-asserted-by":"publisher","first-page":"abstr6001","DOI":"10.1200\/JCO.2024.42.16_suppl.6001","volume":"42","author":"H-Q Mai","year":"2024","unstructured":"Mai H-Q, Liu SL, Chen Q-Y, et al. Tislelizumab versus placebo combined with induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant tislelizumab or placebo for locoregionally advanced nasopharyngeal carcinoma: Interim analysis of a multicenter, randomized,placebo-controlled, double-blind, phase 3 trial. J Clin Oncol. 2024;42(suppl 16):abstr6001.","journal-title":"J Clin Oncol"},{"issue":"suppl 17","key":"1830_CR12","doi-asserted-by":"publisher","first-page":"abstrLBA6000","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA6000","volume":"42","author":"J Ma","year":"2024","unstructured":"Ma J, Sun Y, Liang Y-L, et al. Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial. J Clin Oncol. 2024;42(suppl 17):abstrLBA6000.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1830_CR13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jamaoncol.2024.4354","volume":"10","author":"JJ Pan","year":"2024","unstructured":"Pan JJ, Mai HQ, Ng WT, Hu CS, Li JG, Chen XZ. Ninth version of the AJCC and UICC nasopharyngeal cancer TNM staging classification. JAMA Oncol. 2024;10(12):1627\u201335.","journal-title":"JAMA Oncol"},{"issue":"4","key":"1830_CR14","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1021\/acs.analchem.0c03778","volume":"93","author":"C Shu","year":"2021","unstructured":"Shu C, Zheng W, Lin K, Lim C, Huang Z. Label-free follow-up surveying of post-treatment efficacy and recurrence in nasopharyngeal carcinoma patients with fiberoptic Raman endoscopy. Anal Chem. 2021;93(4):2053\u201361.","journal-title":"Anal Chem"},{"issue":"11","key":"1830_CR15","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/cncr.31983","volume":"125","author":"SP Ng","year":"2019","unstructured":"Ng SP, Pollard C 3rd, Berends J, Ayoub Z, Kamal M, Garden AS, et al. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. 2019;125(11):1823\u20139.","journal-title":"Cancer"},{"key":"1830_CR16","doi-asserted-by":"publisher","first-page":"10898","DOI":"10.1021\/acs.analchem.1c01559","volume":"93","author":"C Shu","year":"2021","unstructured":"Shu C, Yan H, Zheng W, Lin K, James A, Selvarajan S, Lim CM, Huang Z. Deep Learning-Guided Fiberoptic Raman Spectroscopy Enables Real-Time In Vivo Diagnosis and Assessment of Nasopharyngeal Carcinoma and Post-treatment Efficacy during Endoscopy. Anal Chem. 2021;93:10898\u2013906.","journal-title":"Anal Chem"},{"key":"1830_CR17","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.ijrobp.2018.01.117","volume":"102","author":"GQ Zhou","year":"2018","unstructured":"Zhou GQ, et al. Cost-effectiveness analysis of routine magnetic resonance imaging in the follow-up of patients with nasopharyngeal carcinoma after intensity modulated radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 2018;102:1382\u201391.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"3","key":"1830_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00259-022-06020-3","volume":"50","author":"PY OuYang","year":"2023","unstructured":"OuYang PY, Liu ZQ, Lin QG, He Y, Guo ZX, Yao WY, Xu SK, Peng QH, Xiao SM, Li J, Li A, Zhang BY, Yang SS, Fan W, Xie CM, Wu YS, Zhang X, Chen CY, Xie FY. Benefit of [18F] FDG PET\/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2023;50(3):881\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1830_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/jso.21257","volume":"100","author":"GH Pantvaidya","year":"2009","unstructured":"Pantvaidya GH, Agarwal JP, Deshpande MS, et al. PET\/CT in recurrent head neck cancers: a study to evaluate impact on patient management. J Surg Oncol. 2009;100:401\u20133.","journal-title":"J Surg Oncol"},{"issue":"52","key":"1830_CR20","doi-asserted-by":"publisher","first-page":"86914","DOI":"10.18632\/oncotarget.13564","volume":"7","author":"W Zhao","year":"2016","unstructured":"Zhao W, Lei H, Zhu X, Li L, Qu S, Liang X. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensitymodulated radiotherapy: a retrospective analysis. Oncotarget. 2016;7(52):86914\u201325.","journal-title":"Oncotarget"},{"key":"1830_CR21","doi-asserted-by":"publisher","first-page":"2163e73","DOI":"10.1002\/cncr.32770","volume":"126","author":"FP Chen","year":"2020","unstructured":"Chen FP, Huang XD, Lv JW, Wen DW, Zhou GQ, Lin L, et al. Prognostic potential of liquid biopsy tracking in the post-treatment surveillance of patients with nonmetastatic nasopharyngeal carcinoma. Cancer. 2020;126:2163e73.","journal-title":"Cancer"},{"issue":"9","key":"1830_CR22","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190691","volume":"39","author":"H Peng","year":"2019","unstructured":"Peng H, Li Z, Long Y, et al. Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis. Biosci Rep. 2019;39(9):BSR20190691.","journal-title":"Biosci Rep"},{"issue":"6","key":"1830_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.oraloncology.2013.02.006","volume":"49","author":"CL Hsu","year":"2013","unstructured":"Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, et al. Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma. Oral Oncol. 2013;49(6):620\u20135.","journal-title":"Oral Oncol"},{"issue":"1","key":"1830_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12916-021-02076-4","volume":"19","author":"CF Wu","year":"2021","unstructured":"Wu CF, Lin L, Mao YP, Deng B, Lv JW, Zheng WH, Wen DW, Kou J, Chen FP, Yang XL, Xu SS, Ma J, Zhou GQ, Sun Y. Liquid biopsy post-treatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA. BMC Med. 2021;19(1):193.","journal-title":"BMC Med"},{"key":"1830_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejca.2021.03.052","volume":"151","author":"FP Chen","year":"2021","unstructured":"Chen FP, Luo YS, Chen K, Li JY, Huo LQ, Shi L, Ou-Yang Y, Cao XP. Circulating Epstein-Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma. Eur J Cancer. 2021;151:63\u201371.","journal-title":"Eur J Cancer"},{"issue":"8","key":"1830_CR26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.ccell.2024.07.001","volume":"42","author":"J Lv","year":"2024","unstructured":"Lv J, Xu LX, Li ZX, Lin L, Wu CF, Quan TQ, Zhen ZC, Li WF, Tang LL, Mao YP, Chen L, Guo R, Zhang LL, Ai XL, Wu SY, Hao MY, Wei D, Li JB, Ma J, Chen YP, Zhou GQ, Sun Y. Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study. Cancer Cell. 2024;42(8):1401\u2013e14144.","journal-title":"Cancer Cell"},{"key":"1830_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110032","volume":"190","author":"CL Huang","year":"2024","unstructured":"Huang CL, Wang GY, Lou JH, Chen L, Li QJ, Li KP, et al. Oral chemotherapy versus observation alone in nasopharyngeal carcinoma patients with persistently detected circulating cell-free Epstein-Barr virus DNA during follow-up. Radiother Oncol. 2024;190:110032.","journal-title":"Radiother Oncol"},{"key":"1830_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115098","volume":"213","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhu L, Lv W, Xu T, Shen C, Qian W, et al. Liquid biopsy with plasma Epstein-Barr virus DNA characterizes biological relapse for the prediction of cancer recurrence in non-disseminated nasopharyngeal carcinoma. Eur J Cancer. 2024;213:115098.","journal-title":"Eur J Cancer"},{"key":"1830_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KCW Wong","year":"2021","unstructured":"Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol. 2021;18:679\u201395.","journal-title":"Nat Rev Clin Oncol"},{"key":"1830_CR30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.4143\/crt.2018.298","volume":"51","author":"LL Zhang","year":"2019","unstructured":"Zhang LL, et al. Risk assessment of secondary primary malignancies in nasopharyngeal carcinoma: a big-data intelligence platform-based analysis of 6,377 long-term survivors from an endemic area treated with intensity-modulated radiation therapy during 20032013. Cancer Res Treat. 2019;51:982\u201391.","journal-title":"Cancer Res Treat"},{"key":"1830_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.oraloncology.2017.11.022","volume":"76","author":"T Xu","year":"2018","unstructured":"Xu T, Zhou X, Shen C, et al. Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: based on hazard-rate and patterns of recurrence. Oral Oncol. 2018;76:61\u20137.","journal-title":"Oral Oncol"},{"issue":"11","key":"1830_CR32","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1002\/cam4.3917","volume":"10","author":"J Wang","year":"2021","unstructured":"Wang J, Huang X, Sun S, Wang K, Qu Y, Chen X, Wu R, Zhang Y, Liu Q, Zhang J, Luo J, Xiao J, Gao L, Xu G, Hu C, Li YX, Yi J. Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillance. Cancer Med. 2021;10(11):3613\u201321.","journal-title":"Cancer Med"},{"key":"1830_CR33","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1002\/cam4.3917","volume":"10","author":"J Wang","year":"2021","unstructured":"Wang J, Huang X, Sun S, Wang K, Qu Y, Chen X, et al. Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: clinical implications for treatment strategies and surveillance. Cancer Med. 2021;10:3613\u201321.","journal-title":"Cancer Med"},{"key":"1830_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109716","volume":"185","author":"T Lu","year":"2023","unstructured":"Lu T, Xu H, Huang W, Zong J, Pan C, Huang C, et al. Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach. Radiother Oncol. 2023;185:109716.","journal-title":"Radiother Oncol"},{"key":"1830_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.105851","volume":"128","author":"ZC Yang","year":"2022","unstructured":"Yang ZC, Nie ZQ, Chen QY, Du CC, Luo DH, Liu LT, et al. Cost-effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission. Oral Oncol. 2022;128:105851.","journal-title":"Oral Oncol"},{"issue":"3","key":"1830_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/hed.27277","volume":"45","author":"Y Feng","year":"2023","unstructured":"Feng Y, Xu Y, Xu T, Hong H, Chen J, Qiu X, et al. Recommendation for imaging follow-up strategy based on time-specific disease failure for nasopharyngeal carcinoma. Head Neck. 2023;45(3):629\u201337.","journal-title":"Head Neck"},{"issue":"1","key":"1830_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1158\/1078-0432.CCR-20-2166","volume":"27","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li ZY, Zhou GQ, Sun Y. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2021;27(1):330\u201341.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1830_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/2056-4538.12391","volume":"10","author":"X Zhou","year":"2024","unstructured":"Zhou X, Ying H, Sun Y, Zhang W, Luo P, Zhu S, et al. Homologous recombination deficiency (HRD) is associated with better prognosis and possibly causes a non-inflamed tumour microenvironment in nasopharyngeal carcinoma. J Pathol Clin Res. 2024;10(5):e12391.","journal-title":"J Pathol Clin Res"},{"issue":"1","key":"1830_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66678-3","volume":"10","author":"FM Chen","year":"2020","unstructured":"Chen FM, Zhang YX, Li XF, Gao JF, Ma H, Wang XL, et al. The prognostic value of deficient mismatch repair in stage II-IVa nasopharyngeal carcinoma in the era of IMRT. Sci Rep. 2020;10(1):9690.","journal-title":"Sci Rep"},{"issue":"4","key":"1830_CR40","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.31557\/APJCP.2021.22.4.1171","volume":"22","author":"K Chatterjee","year":"2021","unstructured":"Chatterjee K, De S, Deb Roy S, Sahu SK, Chakraborty A, Ghatak S, Das N, Mal S, Roy Chattopadhyay N, Das P, Reddy RR, Mukherjee S, Das AK, Puii Z, Zomawia E, Singh YI, Tsering S, Riba K, Rajasubramaniam S, Suryawanshi AR, Choudhuri T. BAX\u2009\u2013\u2009248 G\u2009>\u2009A and BCL2 -938 C\u2009>\u2009A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach. Asian Pac J Cancer Prev. 2021;22(4):1171\u201381.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"24","key":"1830_CR41","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1158\/1078-0432.CCR-20-2854","volume":"26","author":"W Dai","year":"2020","unstructured":"Dai W, Chung DL, Chow LK, Yu VZ, Lei LC, Leong MM, Chan CK, Ko JM, Lung ML. Clinical Outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma. Clin Cancer Res. 2020;26(24):6494\u2013504.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1830_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/14737159.2020.1835473","volume":"20","author":"WCS Cho","year":"2020","unstructured":"Cho WCS, Tse KP, Ngan RKC, Cheuk W, Ma VWS, Yang YT, et al. Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse. Expert Rev Mol Diagn. 2020;20(11):1149\u201359.","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"1830_CR43","first-page":"165","volume":"47","author":"Y Chen","year":"2022","unstructured":"Chen Y, He Q, Ma H, Zhang L, Liu F, Han Y. Relationship of PI3K-Akt\/mTOR\/AMPK signaling pathway genetic mutation with efficacy and prognosis in nasopharyngeal carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47(2):165\u201373.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"1830_CR44","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.2147\/CMAR.S325373","volume":"13","author":"C Yan","year":"2021","unstructured":"Yan C, Shen DS, Chen XB, et al. CT-based radiomics nomogram for prediction of progression-free survival in locoregionally advanced nasopharyngeal carcinoma. Cancer Manag Res. 2021;13:6911\u201323.","journal-title":"Cancer Manag Res"},{"issue":"10","key":"1830_CR45","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.31557\/APJCP.2024.25.10.3507","volume":"25","author":"L Rachmadi","year":"2024","unstructured":"Rachmadi L, Linggodigdo M, Hasan F, Cahyanur R, Salamah T, Susanto YDB. Exploring the Relationship Between YAP (Yes-Associated Protein) and VEGF-A with Distant Metastasis in Nasopharyngeal Carcinoma. Asian Pac J Cancer Prev. 2024;25(10):3507\u201313.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"1830_CR46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41419-024-06687-6","volume":"15","author":"X Ou","year":"2024","unstructured":"Ou X, Zhang Y, Xu Y, Liu Y, Tu W, Hu C, Liu Y. PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker. Cell Death Dis. 2024;15(4):294.","journal-title":"Cell Death Dis"},{"issue":"21","key":"1830_CR47","first-page":"11114","volume":"24","author":"JH Zhong","year":"2020","unstructured":"Zhong JH, Zhong JJ, Shi YN, Hu XM, Xu MJ, Guo Z, Zhong TY, Li WS, Wang Y. Prognostic potentials of miRNA-19a-3p and PDCD5 in nasopharynx carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(21):11114\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1830_CR48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563\u201377.","journal-title":"Radiology"},{"key":"1830_CR49","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1148\/radiol.2016152234","volume":"281","author":"Y Huang","year":"2016","unstructured":"Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z, et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology. 2016;281:947\u201357.","journal-title":"Radiology"},{"issue":"1","key":"1830_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46985-0","volume":"9","author":"X Ming","year":"2019","unstructured":"Ming X, Oei RW, Zhai R, Kong F, Du C, Hu C, et al. MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma. Sci Rep. 2019;9(1):10412. https:\/\/doi.org\/10.1038\/s41598-019-46985-0.","journal-title":"Sci Rep"},{"key":"1830_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637687","volume":"11","author":"C Zhu","year":"2021","unstructured":"Zhu C, Huang H, Liu X, et al. A clinical-radiomics nomogram based on computed tomography for predicting risk of local recurrence after radiotherapy in nasopharyngeal carcinoma. Front Oncol. 2021;11:637687.","journal-title":"Front Oncol"},{"key":"1830_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102958","volume":"12","author":"M Bologna","year":"2020","unstructured":"Bologna M, Corino V, Calareso G, et al. Baseline MRI-radiomics can predict overall survival in non-endemic EBV-related nasopharyngeal carcinoma patients. Cancers. 2020;12:2958.","journal-title":"Cancers"},{"key":"1830_CR53","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/jmri.27633","volume":"54","author":"S Wu","year":"2021","unstructured":"Wu S, Li H, Dong A, et al. Differences in radiomics signatures between patients with early and advanced T-stage nasopharyngeal carcinoma facilitate prognostication. J Magn Reson Imaging. 2021;54:854\u201365.","journal-title":"J Magn Reson Imaging"},{"key":"1830_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1758835920971416","volume":"12","author":"F Zhang","year":"2020","unstructured":"Zhang F, Zhong LZ, Zhao X, et al. A deep-learning-based prognostic nomogram integrating microscopic digital pathology and macroscopic magnetic resonance images in nasopharyngeal carcinoma: a multi-cohort study. Ther Adv Med Oncol. 2020;12:1\u201312.","journal-title":"Ther Adv Med Oncol"},{"key":"1830_CR55","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12149-021-01585-9","volume":"35","author":"L Peng","year":"2021","unstructured":"Peng L, Hong X, Yuan Q, Lu L, Wang Q, Chen W. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET\/CT images. Ann Nucl Med. 2021;35:458\u201368.","journal-title":"Ann Nucl Med"},{"key":"1830_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.794975","volume":"12","author":"HJ Li","year":"2022","unstructured":"Li HJ, Liu LZ, Huang Y, Jin YB, Chen XP, Luo W, et al. Establishment and validation of a novel MRI radiomics feature-based prognostic model to predict distant metastasis in endemic nasopharyngeal carcinoma. Front Oncol. 2022;12:794975. https:\/\/doi.org\/10.3389\/fonc.2022.794975.","journal-title":"Front Oncol"},{"issue":"1","key":"1830_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40644-022-00448-4","volume":"22","author":"D Bao","year":"2022","unstructured":"Bao D, Liu Z, Geng Y, Li L, Xu H, Zhang Y, Hu L, Zhao X, Zhao Y, Luo D. Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment. Cancer Imaging. 2022;22(1):10. https:\/\/doi.org\/10.1186\/s40644-022-00448-4.","journal-title":"Cancer Imaging"},{"issue":"13","key":"1830_CR58","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.3390\/cancers14133201","volume":"14","author":"Q Hu","year":"2022","unstructured":"Hu Q, Wang G, Song X, Wan J, Li M, Zhang F, Chen Q, Cao X, Li S, Wang Y. Machine Learning Based on MRI DWI Radiomics Features for Prognostic Prediction in Nasopharyngeal Carcinoma. Cancers (Basel). 2022;14(13):3201.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1830_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101180","volume":"14","author":"MJ Kim","year":"2021","unstructured":"Kim MJ, Choi Y, Sung YE, Lee YS, Kim YS, Ahn KJ, et al. Early risk-assessment of patients with nasopharyngeal carcinoma: the added prognostic value of MR-based radiomics. Transl Oncol. 2021;14(10):101180.","journal-title":"Transl Oncol"},{"key":"1830_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.774455","volume":"11","author":"L Kang","year":"2021","unstructured":"Kang L, Niu Y, Huang R, Lin SY, Tang Q, Chen A, et al. Predictive value of a combined model based on pre-treatment and mid-treatment MRI-radiomics for disease progression or death in locally advanced nasopharyngeal carcinoma. Front Oncol. 2021;11:774455.","journal-title":"Front Oncol"},{"issue":"1","key":"1830_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s42492-023-00149-0","volume":"6","author":"H Li","year":"2023","unstructured":"Li H, Huang W, Wang S, Balasubramanian PS, Wu G, Fang M, Xie X, Zhang J, Dong D, Tian J, Chen F. Comprehensive integrated analysis of MR and DCE-MR radiomics models for prognostic prediction in nasopharyngeal carcinoma. Vis Comput Ind Biomed Art. 2023;6(1):23.","journal-title":"Vis Comput Ind Biomed Art"},{"issue":"10","key":"1830_CR62","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1007\/s00330-023-09606-z","volume":"33","author":"H Xu","year":"2023","unstructured":"Xu H, Lv W, Zhang H, Yuan Q, Wang Q, Wu Y, Lu L. Multimodality radiomics analysis based on [18F]FDG PET\/CT imaging and multisequence MRI: application to nasopharyngeal carcinoma prognosis. Eur Radiol. 2023;33(10):6677\u201388.","journal-title":"Eur Radiol"},{"key":"1830_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.815952","volume":"12","author":"ZY Fang","year":"2022","unstructured":"Fang ZY, Li KZ, Yang M, Che YR, Luo LP, Wu ZF, et al. Integration of MRI-based radiomics features, clinicopathological characteristics, and blood parameters: a nomogram model for predicting clinical outcome in nasopharyngeal carcinoma. Front Oncol. 2022;12:815952. https:\/\/doi.org\/10.3389\/fonc.2022.815952.","journal-title":"Front Oncol"},{"key":"1830_CR64","doi-asserted-by":"crossref","unstructured":"Xie HJ, Sun XS, Zhang X, Xiao BB, Lin DF, Lin XP, Lv XF, Liu LZ, Han F, Zou RH, Li JB, Fan W, Chen QY, Mai HQ, Tang LQ. Headand neck MRI-based T stage and [18F]FDG PET\/CT-based N\/M stage improved prognostic stratification in primary nasopharyngealcarcinoma. Eur Radiol. 2023;33(11):7952\u201366.","DOI":"10.1007\/s00330-023-09815-6"},{"issue":"4","key":"1830_CR65","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/cas.15704","volume":"114","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wu G, Yang Q, Dai G, Li T, Chen P, Li J, Huang W. Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network. Cancer Sci. 2023;114(4):1596\u2013605. https:\/\/doi.org\/10.1111\/cas.15704.","journal-title":"Cancer Sci"},{"issue":"13","key":"1830_CR66","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1007\/s00259-023-06399-7","volume":"50","author":"B Gu","year":"2023","unstructured":"Gu B, Meng M, Xu M, Feng DD, Bi L, Kim J, Song S. Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2023;50(13):3996\u20134009.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1830_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10020-022-00479-4","volume":"28","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Li P, Zhang X, Xu J, Xu J, Yu S, Wang D, Dong W, Cao X, Yan H, Sun M, Ding X, Xing J, Zhang P, Zhai L, Fan T, Tian S, Yang X, Hu M. Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes. Mol Med. 2022;28(1):55.","journal-title":"Mol Med"},{"key":"1830_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105335","volume":"118","author":"X Chen","year":"2021","unstructured":"Chen X, Li Y, Li X, Cao X, Xiang Y, Xia W, et al. An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features. Oral Oncol. 2021;118:105335.","journal-title":"Oral Oncol"},{"issue":"11","key":"1830_CR69","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1007\/s00405-023-08084-9","volume":"280","author":"C Yang","year":"2023","unstructured":"Yang C, Chen Y, Zhu L, Wang L, Lin Q. A deep learning MRI-based signature may provide risk-stratification strategies for nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol. 2023;280(11):5039\u201347.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1830_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.955866","volume":"12","author":"WZ Li","year":"2022","unstructured":"Li WZ, Wu G, Li TS, Dai GM, Liao YT, Yang QY, et al. Dynamic contrast-enhanced magnetic resonance imaging-based radiomics for the prediction of progression-free survival in advanced nasopharyngeal carcinoma. Front Oncol. 2022;12:955866.","journal-title":"Front Oncol"},{"issue":"9","key":"1830_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104841","volume":"25","author":"X Cao","year":"2022","unstructured":"Cao X, Chen X, Lin ZC, Liang CX, Huang YY, Cai ZC, et al. Add-on individualizing prediction of nasopharyngeal carcinoma using deep-learning based on MRI: a multicentre, validation study. iScience. 2022;25(9):104841.","journal-title":"iScience"},{"key":"1830_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2020.105684","volume":"197","author":"B Jing","year":"2020","unstructured":"Jing B, Deng Y, Zhang T, Hou D, Li B, Qiang M, et al. Deep learning for risk prediction in patients with nasopharyngeal carcinoma using multi-parametric MRIs. Comput Methods Programs Biomed. 2020;197:105684.","journal-title":"Comput Methods Programs Biomed"},{"key":"1830_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.109445","volume":"179","author":"JR Mao","year":"2023","unstructured":"Mao JR, Lan KQ, Liu SL, Liu C, Xie SY, Li SC, et al. Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission? Radiother Oncol. 2023;179:109445.","journal-title":"Radiother Oncol"},{"issue":"11","key":"1830_CR74","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1002\/cam4.3839","volume":"10","author":"C Lai","year":"2021","unstructured":"Lai C, Zhang C, Lv H, Huang H, Ke X, Zhou C, Chen H, Chen S, Zhou L. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers. Cancer Med. 2021;10(11):3511\u201323.","journal-title":"Cancer Med"},{"issue":"1","key":"1830_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cac2.12113","volume":"41","author":"CF Wu","year":"2021","unstructured":"Wu CF, Lv JW, Lin L, Mao YP, Deng B, Zheng WH, Wen DW, Chen Y, Kou J, Chen FP, Yang XL, Zheng ZQ, Li ZX, Xu SS, Ma J, Sun Y. Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases. Cancer Commun (Lond). 2021;41(1):37\u201350.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"1830_CR76","volume":"23","author":"M Wang","year":"2025","unstructured":"Wang M, Yao Q, Zhu W, Xiao N, Dai L. Machine learning model for predicting recurrence following intensity-modulated radiation therapy in nasopharyngeal carcinoma. World J Surg Oncol. 2025;23(1):237.78.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"1830_CR77","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ijrobp.2022.03.011","volume":"113","author":"R Ni","year":"2022","unstructured":"Ni R, Zhou T, Ren G, Zhang Y, Yang D, Tam VCW, Leung WS, Ge H, Lee SWY, Cai J. Deep Learning-Based Automatic Assessment of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2022;113(3):685\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1830_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102202","volume":"63","author":"PY OuYang","year":"2023","unstructured":"OuYang PY, He Y, Guo JG, Liu JN, Wang ZL, Li A, et al. Artificial intelligence aided precise detection of local recurrence on MRI for nasopharyngeal carcinoma: a multicenter cohort study. EClinicalMedicine. 2023;63:102202.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1830_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-00186-0","volume":"15","author":"Q Wu","year":"2025","unstructured":"Wu Q, Qiang W, Pan L, Cha T, Li Q, Gao Y, et al. Performance of MRI-based radiomics for prediction of residual disease status in patients with nasopharyngeal carcinoma after radical radiotherapy. Sci Rep. 2025;15(1):16758.","journal-title":"Sci Rep"},{"key":"1830_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.774455","volume":"11","author":"L Kang","year":"2021","unstructured":"Kang L, Niu Y, Huang R, Lin SY, Tang Q, Chen A, et al. Predictive value of a combined model based on pre-treatment and mid-treatment MRI-radiomics for disease progression or death in locally advanced nasopharyngeal carcinoma. Front Oncol. 2021;11:774455.","journal-title":"Front Oncol"},{"key":"1830_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdent.2023.104518","volume":"134","author":"JPZ Ng","year":"2023","unstructured":"Ng JPZ, Lam WYH, Pow EHN, Botelho MG. A qualitative analysis of patient\u2019s lived experience on their treatment journey with nasopharyngeal carcinoma. J Dent. 2023;134:104518.","journal-title":"J Dent"},{"issue":"1","key":"1830_CR82","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41746-025-01918-2","volume":"8","author":"Y Liu","year":"2025","unstructured":"Liu Y, Yan W, Chen Y, Miao J, Zhang H, Wang J, Zhang Y, Huang X, Wang K, Qu Y, Chen X, Zhang J, Luo J, Li YX, Zhao C, Ma J, Wu R, Yi J. Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma. NPJ Digit Med. 2025;8(1):564.","journal-title":"NPJ Digit Med"},{"issue":"4","key":"1830_CR83","doi-asserted-by":"publisher","first-page":"e18974","DOI":"10.1097\/MD.0000000000018974","volume":"99","author":"J Wu","year":"2020","unstructured":"Wu J, Zhou Q, Pan Z, Wang Y, Hu L, Chen G, et al. Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma: a population-based study. Medicine. 2020;99(4):e18974.","journal-title":"Medicine"},{"key":"1830_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.583283","volume":"11","author":"ZZ Huang","year":"2021","unstructured":"Huang ZZ, Wen W, Hua X, Song CG, Bi XW, Huang JJ, et al. Establishment and validation of nomogram based on combination of pretreatment C-reactive protein\/albumin ratio-EBV DNA grade in nasopharyngeal carcinoma patients who received concurrent chemoradiotherapy. Front Oncol. 2021;11:583283.","journal-title":"Front Oncol"},{"issue":"1","key":"1830_CR85","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12935-022-02776-8","volume":"22","author":"S Miao","year":"2022","unstructured":"Miao S, Lei H, Li X, Zhou W, Wang G, Sun A, Wang Y, Wu Y. Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China. Cancer Cell Int. 2022;22(1):360.","journal-title":"Cancer Cell Int"},{"key":"1830_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683475","volume":"11","author":"YT Jiang","year":"2021","unstructured":"Jiang YT, Chen KH, Yang J, Liang ZG, Qu S, Li L, et al. Establishment of a prognostic nomogram for patients with locoregionally advanced nasopharyngeal carcinoma incorporating TNM stage, post-induction chemotherapy tumor volume and Epstein-Barr virus DNA load. Front Oncol. 2021;11:683475.","journal-title":"Front Oncol"},{"key":"1830_CR87","doi-asserted-by":"publisher","first-page":"6618728","DOI":"10.1155\/mi\/6618728","volume":"2025","author":"S Wang","year":"2025","unstructured":"Wang S, Feng Y, Ling J, Zhao X, Hu Y, Hou T, Xie Y. Nomograms Based on Blood-Based Biomarkers for Predicting Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients. Mediators Inflamm. 2025;2025:6618728.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"1830_CR88","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12967-023-03912-2","volume":"21","author":"X Xu","year":"2023","unstructured":"Xu X, Wei F, Xiao L, Wu R, Wei B, Huang S, Yi J, Cui W. High proportion of circulating CD8\u2009+\u2009CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal canrcinoma after radiotherapy. J Transl Med. 2023;21(1):64.","journal-title":"J Transl Med"},{"issue":"14","key":"1830_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12141452","volume":"12","author":"S Chen","year":"2024","unstructured":"Chen S, Feng C, Sun P, Zhang J, Liang H. Effect of online clinic on follow-up compliance and survival outcomes in nasopharyngeal carcinoma: real-world cohort study from endemic area. Healthcare (Basel). 2024;12(14):1452.","journal-title":"Healthcare (Basel)"},{"key":"1830_CR90","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/cac2.12218","volume":"41","author":"LL Tang","year":"2021","unstructured":"Tang LL, Chen YP, Chen CB, Chen MY, Chen NY, Chen XZ, et al. The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun (Lond). 2021;41:1195\u2013227.","journal-title":"Cancer Commun (Lond)"},{"key":"1830_CR91","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","volume":"32","author":"P Bossi","year":"2021","unstructured":"Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, et al. Nasopharyngeal carcinoma: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up(y). Ann Oncol. 2021;32:452\u201365.","journal-title":"Ann Oncol"},{"issue":"2","key":"1830_CR92","doi-asserted-by":"publisher","first-page":"2","DOI":"10.6004\/jnccn.2025.0007","volume":"23","author":"AD Colevas","year":"2025","unstructured":"Colevas AD, Cmelak AJ, Pfister DG, Spencer S, Adkins D, Birkeland AC, Brizel DM, Busse PM, Caudell JJ, Durm G, Fakhry C, Galloway T, Geiger JL, Gillison ML, Glastonbury C, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Juloori A, Kase M, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Price K, Rocco JW, Rodriguez CP, Schwartz D, Shah JP, Sher D, John MS, Wang H, Weinstein G, Worden F, Bruce JY, Yom SS, Zhen W, Montgomery S, Darlow SD. NCCN Guidelines\u00ae Insights: Head and Neck Cancers, Version 2.2025. J Natl Compr Canc Netw. 2025;23(2):2\u201311.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1830_CR93","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1038\/s41467-020-17672-w","volume":"11","author":"GQ Zhou","year":"2020","unstructured":"Zhou GQ, Wu CF, Deng B, Gao TS, Lv JW, Lin L, Chen FP, Kou J, Zhang ZX, Huang XD, Zheng ZQ, Ma J, Liang JH, Sun Y. An optimal post-treatment surveillance strategy for cancer survivors based on an individualized risk-based approach. Nat Commun. 2020;11(1):3872.","journal-title":"Nat Commun"},{"issue":"1","key":"1830_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01292-5","volume":"20","author":"YP Chen","year":"2021","unstructured":"Chen YP, Lv JW, Mao YP, Li XM, Li JY, Wang YQ, et al. Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses. Mol Cancer. 2021;20(1):14.","journal-title":"Mol Cancer"},{"issue":"21","key":"1830_CR95","first-page":"11114","volume":"24","author":"JH Zhong","year":"2020","unstructured":"Zhong JH, Zhong JJ, Shi YN, Hu XM, Xu MJ, Guo Z, Zhong TY, Li WS, Wang Y. Prognostic potentials of miRNA-19a-3p and PDCD5 in nasopharynx carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(21):11114\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"1830_CR96","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/jnci\/djae081","volume":"116","author":"DF Lin","year":"2024","unstructured":"Lin DF, Li HL, Liu T, Lv XF, Xie CM, Ou XM, et al. Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma. J Natl Cancer Inst. 2024;116(8):1294\u2013302.","journal-title":"J Natl Cancer Inst"},{"key":"1830_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111084","volume":"168","author":"Y Deng","year":"2023","unstructured":"Deng Y, Huang Y, Jing B, Wu H, Qiu W, Chen H, et al. Deep learning-based recurrence detector on magnetic resonance scans in nasopharyngeal carcinoma: a multicenter study. Eur J Radiol. 2023;168:111084.","journal-title":"Eur J Radiol"},{"issue":"4","key":"1830_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70143","volume":"6","author":"Y Liu","year":"2020","unstructured":"Liu Y, Han Y, Feng M, Zhang Y, Wang K, Qu Y, et al. Subsequent survival and loss of lifetime for patients with progression-free 24 months after treatment in nasopharyngeal carcinoma: a comprehensive nationwide population-based analysis. MedComm (Beijing). 2020;6(4):e70143.","journal-title":"MedComm (Beijing)"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01830-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01830-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01830-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:02:25Z","timestamp":1789534945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-026-01830-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1830"],"URL":"https:\/\/doi.org\/10.1007\/s11912-026-01830-2","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"94"}}